Stimulation of bone healing by sustained bone morphogenetic protein 2 (BMP-2) delivery

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 8539-8552

  Faßbender, Mirja ^a   Minkwitz, Susann ^a   Strobel, Catrin ^a   Schmidmaier, Gerhard ^b   Wildemann, Britt ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Biomechanical testing; Histology; Impaired bone healing; Implant coating; Micro computed tomography ( CT); Sustained bone morphogenetic protein 2 (BMP 2) release

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DRUG CARRIER; LACTIC ACID; POLYLACTIC ACID; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CONTROLLED STUDY; FEMALE; FRACTURE HEALING; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; RAT; TIBIA OSTEOTOMY; ANIMAL; BONE; BONE REGENERATION; CARTILAGE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECTS; PHYSIOLOGY; RADIOGRAPHY; SPRAGUE DAWLEY RAT; SURGERY; TIME; WOUND HEALING;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CARTILAGE; DRUG CARRIERS; FEMALE; LACTIC ACID; MODELS, ANIMAL; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; WOUND HEALING;

EID: 84900800497     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15058539     Document Type: Article

References (30)

1. Claes, L.; Recknagel, S.; Ignatius, A. Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol. 2012, 8, 133-143.
2. Ai-Aql, Z.S.; Alagl, A.S.; Graves, D.T.; Gerstenfeld, L.C.; Einhorn, T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J. Dent. Res. 2008, 87, 107-118.
3. Onishi, T.; Ishidou, Y.; Nagamine, T.; Yone, K.; Imamura, T.; Kato, M.; Sampath, T.K.; ten Dijke, P.; Sakou, T. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 1998, 22, 605-612.
4. Kwong, F.N.; Hoyland, J.A.; Freemont, A.J.; Evans, C.H. Altered relative expression of BMPs and BMP inhibitors in cartilaginous areas of human fractures progressing towards nonunion. J. Orthop. Res. 2009, 27, 752-757.
5. David, L.; Feige, J.J.; Bailly, S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev. 2009, 20, 203-212.
6. Tsuji, K.; Bandyopadhyay, A.; Harfe, B.D.; Cox, K.; Kakar, S.; Gerstenfeld, L.; Einhorn, T.; Tabin, C.J.; Rosen, V. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 2006, 38, 1424-1429.
7. Nauth, A.; Giannoudis, P.V.; Einhorn, T.A.; Hankenson, K.D.; Friedlaender, G.E.; Li, R.; Schemitsch, E.H. Growth factors: Beyond bone morphogenetic proteins. J. Orthop. Trauma 2010, 24, 543-546.
8. Govender, S.; Csimma, C.; Genant, H.K.; Valentin-Opran, A.; Amit, Y.; Arbel, R.; Aro, H.; Atar, D.; Bishay, M.; Börner, M.G.; et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Jt. Surg. Am. 2002, 84, 2123-2134.
9. Kanakaris, N.K.; Calori, G.M.; Verdonk, R.; Burssens, P.; de Biase, P.; Capanna, R.; Vangosa, L.B.; Cherubino, P.; Baldo, F.; Ristiniemi, J.; et al. Application of BMP-7 to tibial non-unions: A 3-year multicenter experience. Injury 2008, 39, S83-S90.
10. Cho, T.J.; Gerstenfeld, L.C.; Einhorn, T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J. Bone Miner. Res. 2002, 17, 513-520.
11. Lienau, J.; Schmidt-Bleek, K.; Peters, A.; Weber, H.; Bail, H.J.; Duda, G.; Perka, C.; Schell, H. Insight into the molecular patho-physiology of delayed bone healing in a sheep model. Tissue Eng. Part A 2010, 16, 191-199.
12. Niikura, T.; Hak, D.J.; Reddi, A.H. Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures. J. Orthop. Res. 2006, 24, 1463-1471.
13. Yu, Y.Y.; Lieu, S.; Lu, C.; Miclau, T.; Marcucio, R.S.; Colnot, C. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone 2010, 46, 841-851.
14. Asamura, S.; Mochizuki, Y.; Yamamoto, M.; Tabata, Y.; Isogai, N. Bone regeneration using a bone morphogenetic protein-2 saturated slow-release gelatin hydrogel sheet: Evaluation in a canine orbital floor fracture model. Ann. Plast. Surg. 2010, 64, 496-502.
15. Wu, G.; Liu, Y.; Iizuka, T.; Hunziker, E.B. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. Biomaterials 2010, 31, 7485-7493.
16. Betz, O.B.; Betz, V.M.; Nazarian, A.; Egermann, M.; Gerstenfeld, L.C.; Einhorn, T.A.; Vrahas, M.S.; Bouxsein, M.L.; Evans, C.H. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther. 2007, 14, 1039-1044.
17. Strobel, C.; Bormann, N.; Kadow-Romacker, A.; Schmidmaier, G.; Wildemann, B. Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants. J. Control. Release 2011, 156, 37-45.
18. Kratzel, C.; Bergmann, C.; Duda, G.; Greiner, S.; Schmidmaier, G.; Wildemann, B. Characterization of a rat osteotomy model with impaired healing. BMC Musculoskelet. Disord. 2008, 9, doi:10.1186/1471-2474-9-135.
19. Wildemann, B.; Lange, K.; Strobel, C.; Fassbender, M.; Willie, B.; Schmidmaier, G. Local BMP-2 application can rescue the delayed osteotomy healing in a rat model. Injury 2011, 42, 746-752.
20. Schmidmaier, G.; Wildemann, B.; Stemberger, A.; Haas, N.P.; Raschke, M. Biodegradable poly(D, L-lactide) coating of implants for continuous release of growth factors. J. Biomed. Mater. Res. 2001, 58, 449-455.
21. Cook, S.D.; Baffes, G.C.; Wolfe, M.W.; Sampath, T.K.; Rueger, D.C.; Whitecloud, T.S. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone Jt. Surg. Am. 1994, 76, 827-838.
22. Cipitria, A.; Reichert, J.C.; Epari, D.R.; Saifzadeh, S.; Berner, A.; Schell, H.; Mehta, M.; Schuetz, M.A.; Duda, G.N.; Hutmacher, D.W. Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae. Biomaterials 2013, 34, 9960-9968.
23. Becker, S.T.; Bolte, H.; Schunemann, K.; Seitz, H.; Bara, J.J.; Beck-Broichsitter, B.E.; Russo, P.A.; Wiltfang, J.; Warnke, P.H. Endocultivation: the influence of delayed vs simultaneous application of BMP-2 onto individually formed hydroxyapatite matrices for heterotopic bone induction. Int. J. Oral Maxillofac. Surg. 2012, 41, 1153-1160.
24. Virk, M.S.; Conduah, A.; Park, S.H.; Liu, N.; Sugiyama, O.; Cuomo, A.; Kang, C.; Lieberman, J.R. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 2008, 42, 921-931.
25. Liu, T.; Wu, G.; Wismeijer, D.; Gu, Z.; Liu, Y. Deproteinized bovine bone functionalized with the slow delivery of BMP-2 for the repair of critical-sized bone defects in sheep. Bone 2013, 56, 110-118.
26. Bodde, E.W.; Boerman, O.C.; Russel, F.G.; Mikos, A.G.; Spauwen, P.H.; Jansen, J.A. The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J. Biomed. Mater. Res. A 2008, 87, 780-791.
27. Wildemann, B.; Lubberstedt, M.; Haas, N.P.; Raschke, M.; Schmidmaier, G. IGF-I and TGF-beta 1 incorporated in a poly(D, L-lactide) implant coating maintain their activity over long-term storage-cell culture studies on primary human osteoblast-like cells. Biomaterials 2004, 25, 3639-3644.
28. Wildemann, B.; Sander, A.; Schwabe, P.; Lucke, M.; Stockle, U.; Raschke, M.; Haas, N.P.; Schmidmaier, G. Short term in vivo biocompatibility testing of biodegradable poly(D, L-lactide)-growth factor coating for orthopaedic implants. Biomaterials 2005, 26, 4035-4040.
29. Greiner, S.H.; Wildemann, B.; Back, D.A.; Alidoust, M.; Schwabe, P.; Haas, N.P.; Schmidmaier, G. Local application of zoledronic acid incorporated in a poly(D, L-lactide)-coated implant accelerates fracture healing in rats. Acta. Orthop. 2008, 79, 717-725.
30. Fassbender, M.; Minkwitz, S.; Kronbach, Z.; Strobel, C.; Kadow-Romacker, A.; Schmidmaier, G.; Wildemann, B. Local gentamicin application does not interfere with bone healing in a rat model. Bone 2013, 55, 298-304.